Ligand Pharmaceuticals
LGND
LGND
261 hedge funds and large institutions have $1.69B invested in Ligand Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 71 increasing their positions, 111 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $2.37B → $1.69B (-$675M)
36% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 111
41% less call options, than puts
Call options by funds: $47.4M | Put options by funds: $80.5M
Holders
261
Holding in Top 10
6
Calls
$47.4M
Puts
$80.5M
Top Buyers
| 1 | +$50.2M | |
| 2 | +$46.2M | |
| 3 | +$20.8M | |
| 4 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$12.5M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$11.7M |
Top Sellers
| 1 | -$30.6M | |
| 2 | -$30.5M | |
| 3 | -$18.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$17.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$16.4M |